

























































asgow Coma Scale：E1V1M1，Japan Coma 








BZO, benzodiazepine; TCA, tricyclic antidepressant
HbA1cはNGSP（National Glycohemoglobin Standardization Program）相当値として表記。
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A case where intramuscular glucagon infusion signifiĮ
cantly improved prolonged hypoglycemia caused by an 
overdose of insulin aspart and insulin detemir
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　A 36-year-old woman, who was undergoing treatment for type2 diabetes melitus, 
attempted suicide by medicinal intoxication and subcutaneously injected herself with 
approximately 300 U of insulin aspart and 300 U of insulin detemir. She was admitted to 
the emergency department 10 hours after the injections. She recovered from hypoglyce-
mia on being injected with 10g glucose. Five hours later, she showed recurrent 
hypoglycemia and did not respond to glucose injection. Therefore, we treated her using 
glucagon infusion and continuous glucose infusion. Infusing glucagon intravenously or 
intramuscularly normalized her blood glucose level. 
　Continuous high-concentration glucose infusion and glucagon injection are 
recommend-ed for patients who develop hypoglycemia because of insulin overdose. 
　A central venous catheter is required for continuous high-concentration glucose 
infusion. However, the use of a central venous catheter carries a high risk of infection 
and thrombosis. 
　Our results indicate that glucagon infusion performed without using a central venous 
catheter can be used for normalizing blood glucose levels. Thus, glucagon infusion 
seems to be a useful tool for managing hypoglycemia.
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